596.76
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché UTHR Giù?
Forum
Previsione
Frazionamento azionario
United Therapeutics Corp Borsa (UTHR) Ultime notizie
United Therapeutics CEO Rothblatt sells $5.47m in stock - Investing.com
United Therapeutics Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
BTIG reiterates Neutral on United Therapeutics stock after Q1 miss By Investing.com - Investing.com Canada
United Therapeutics Q1 2026 slides: IPF breakthrough offsets revenue miss - Investing.com
Transcript: United Therapeutics Q1 2026 Earnings Conference Call - Benzinga
Earnings call transcript: United Therapeutics misses Q1 2026 earnings forecast - Investing.com
Earnings call transcript: United Therapeutics misses Q1 2026 earnings forecast By Investing.com - Investing.com Canada
MannKind stock surges on United Therapeutics partnership deal - Investing.com
United Therapeutics stock hits all-time high at 608.87 USD - Investing.com
United Therapeutics (NASDAQ:UTHR) Reports Sales Below Analyst Estimates In Q1 CY2026 Earnings - StockStory
United Therapeutics (UTHR) Misses Q1 Earnings and Revenue Estimates - Yahoo Finance
United Therapeutics (NASDAQ:UTHR) Shares Dip After Q1 2026 Earnings Miss - ChartMill
MannKind develops inhaled ralinepag formulation for United Therapeutics - Investing.com
MannKind develops inhaled ralinepag formulation for United Therapeutics By Investing.com - Investing.com Canada
MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases - The Manila Times
United Therapeutics Corporation Reports First Quarter 2026 Financial Results - United Therapeutics Investor Relations
United Therapeutics: Q1 Earnings Snapshot - kare11.com
MannKind Announces Ralinepag Dry Powder Inhalation (DPI) - GlobeNewswire
Martine Rothblatt, United Therapeutics CEO, sells $5.48m in shares By Investing.com - Investing.com India
Martine Rothblatt, United Therapeutics CEO, sells $5.48m in shares - Investing.com
United Therapeutics faces earnings test as IPF expansion looms - Investing.com
United Therapeutics Corp (UTHR) - MSN
Transplants.org Launches as Centralized Education and Navigation Platform for Organ and Stem Cell Transplant Patients - GlobeNewswire Inc.
United Therapeutics CEO Rothblatt sells $5.4m in company shares - Investing.com
MSN Money - MSN
UBS raises United Therapeutics stock price target to $705 on catalysts - Investing.com
Mitsubishi UFJ Trust & Banking Corp Sells 26,252 Shares of United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics (NASDAQ:UTHR) CFO James Edgemond Sells 10,000 Shares - MarketBeat
United Therapeutics chairperson & CEO Rothblatt sells $5.44m shares By Investing.com - Investing.com Nigeria
United Therapeutics CFO James Edgemond sells $5.7m in stock By Investing.com - Investing.com Canada
United Therapeutics CFO James Edgemond sells $5.7m in stock - Investing.com
United Therapeutics chairperson & CEO Rothblatt sells $5.44m shares - Investing.com
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 9,500 Shares - MarketBeat
The Beat: nVent doubles capacity for data centers, pig transplant research, Sanuwave doubles HQ - The Business Journals
Maryland biotech business buys 207 acres in Minnesota for pig transplant research - The Business Journals
Vanguard Group Inc. Lowers Stock Position in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics chairperson & CEO Martine Rothblatt sells $5.4m in stock - Investing.com Nigeria
United Therapeutics Director Raymond Dwek to Retire From Board in June 2026 - citybiz
United Therapeutics stock surges 32% in 6 months: Here's why - MSN
Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat
United Therapeutics CEO Martine Rothblatt sells $5.4m in stock By Investing.com - Investing.com India
United Therapeutics CEO Martine Rothblatt sells $5.4m in stock - Investing.com
United Therapeutics CFO James Edgemond sells $5.69m in stock By Investing.com - Investing.com Australia
United Therapeutics (NASDAQ:UTHR) CFO Sells $5,688,300.00 in Stock - MarketBeat
United Therapeutics CFO James Edgemond sells $5.69m in stock - Investing.com
Firm working on pig-to-human transplants paid $8.5 million for 200 acres near Stewartville - Post Bulletin
United Therapeutics Corp at TD Cowen Healthcare Conference Transcript - GuruFocus
Pictet Asset Management Holding SA Sells 14,658 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Teacher Retirement System of Texas Decreases Position in United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics CEO Martine Rothblatt sells $5.37m in shares By Investing.com - Investing.com Australia
United Therapeutics CEO Martine Rothblatt sells $5.37m in shares - Investing.com
United Therapeutics Corporation $UTHR Shares Purchased by Teachers Retirement System of The State of Kentucky - MarketBeat
United Therapeutics Corporation (UTHR) Stock Analysis: Evaluating Growth Potential and Analyst Consensus - DirectorsTalk Interviews
United Therapeutics Corporation $UTHR Shares Bought by Comerica Bank - MarketBeat
Anchyra Partners LLC Buys New Position in United Therapeutics Corporation $UTHR - MarketBeat
Quent Capital LLC Buys 3,323 Shares of United Therapeutics Corporation $UTHR - MarketBeat
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):